Browsing by Author "Ameur, Melissa"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Polypyrimidine tract-binding protein binds to the 5' untranslated region of the mouse mammary tumor virus mRNA. and stimulates cap-independent translation initiation
    (2016) Cáceres, Carlos J.; Contreras, Nataly; Angulo, Jenniffer; Vera Otarola, Jorge; Pino Ajenjo, Constanza; Llorian, Miriam; Ameur, Melissa; Lisboa, Francisco; Pino, Karla; López Lastra, Marcelo Andrés; Lowy de la Torre, Fernando; Sargueil, Bruno
  • No Thumbnail Available
    Item
    Polypyrimidine-Tract-Binding Protein Isoforms Differentially Regulate the Hepatitis C Virus Internal Ribosome Entry Site
    (2023) Angulo, Jenniffer; Caceres, C. Joaquin; Contreras, Nataly; Fernandez-Garcia, Leandro; Chamond, Nathalie; Ameur, Melissa; Sargueil, Bruno; Lopez-Lastra, Marcelo
    Translation initiation of the hepatitis C virus (HCV) mRNA depends on an internal ribosome entry site (IRES) that encompasses most of the 5 ' UTR and includes nucleotides of the core coding region. This study shows that the polypyrimidine-tract-binding protein (PTB), an RNA-binding protein with four RNA recognition motifs (RRMs), binds to the HCV 5 ' UTR, stimulating its IRES activity. There are three isoforms of PTB: PTB1, PTB2, and PTB4. Our results show that PTB1 and PTB4, but not PTB2, stimulate HCV IRES activity in HuH-7 and HEK293T cells. In HuH-7 cells, PTB1 promotes HCV IRES-mediated initiation more strongly than PTB4. Mutations in PTB1, PTB4, RRM1/RRM2, or RRM3/RRM4, which disrupt the RRM's ability to bind RNA, abrogated the protein's capacity to stimulate HCV IRES activity in HuH-7 cells. In HEK293T cells, PTB1 and PTB4 stimulate HCV IRES activity to similar levels. In HEK293T cells, mutations in RRM1/RRM2 did not impact PTB1 ' s ability to promote HCV IRES activity; and mutations in PTB1 RRM3/RRM4 domains reduced, but did not abolish, the protein's capacity to stimulate HCV IRES activity. In HEK293T cells, mutations in PTB4 RRM1/RRM2 abrogated the protein's ability to promote HCV IRES activity, and mutations in RRM3/RRM4 have no impact on PTB4 ability to enhance HCV IRES activity. Therefore, PTB1 and PTB4 differentially stimulate the IRES activity in a cell type-specific manner. We conclude that PTB1 and PTB4, but not PTB2, act as IRES transacting factors of the HCV IRES.